Aleksandr Kolesnikov

816 citations

17 papers · 348 indexed · h-index 10

Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms 11
- Hemophilia Treatment and Research 5
Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 7
Organic Chemistry top 10%
- Synthesis and biological activity 3
Cancer Research
- Protease and Inhibitor Mechanisms 4
Computational Theory and Mathematics
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 3
Molecular Biology
- Phytochemical compounds biological activities 2
- Cancer therapeutics and mechanisms 1

Co-authors: William D. Shrader Paul A. Sprengeler Wendy B. Young B.A. Katz Ellen M. Leahy Roopa Rai Huiyong Hu Erik Verner
Cited by: Hematology Genetics Organic Chemistry
Journals: Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Medicinal Chemistry (2 papers)Synthesis (1 paper)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Aleksandr Kolesnikov

16 papers receiving 310 citations

Peers

Countries citing papers authored by Aleksandr Kolesnikov

Since Specialization

Citations

This map shows the geographic impact of Aleksandr Kolesnikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandr Kolesnikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandr Kolesnikov more than expected).

Fields of papers citing papers by Aleksandr Kolesnikov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksandr Kolesnikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandr Kolesnikov. The network helps show where Aleksandr Kolesnikov may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aleksandr Kolesnikov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aleksandr Kolesnikov Line = papers co-authored together Aleksandr Kolesnikov links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Synthesis of an Azabicyclo[3.1.0]hexanone-Containing Inhibitor of NF-κΒ Inducing Kinase via Catalytic C–H Activation Synthesis ·James J. Crawford,Daohong Liao,Aleksandr Kolesnikov,Wendy Lee,Matthew L. Landry	2020	4
2	Characterizing thein vitrospecies differences in N-glucuronidation of a potent pan-PIM inhibitor GNE-924 containing a 3,5-substituted 6-azaindazole Xenobiotica ·Molly Lin,Justin Q. Ly,Ryan Takahashi,John Chen,Alan Deese,DANIELY PESSOA MOREIRA,Aleksandr Kolesnikov,Susan Wong,Xiaojing Wang,Jae H. Chang	2017	0
3	Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability Journal of Medicinal Chemistry ·Xiaojing Wang,Aleksandr Kolesnikov,Suzanne Tay,Grace Chan,Qi Chao,Steven Do,Jason Drummond,Allen Ebens,Ning Liu,Justin Q. Ly,Eric B. Harstad,Huiyong Hu,John G. Moffat,Veerendra Munugalavadla,Jeremy Murray,Dionysos Slaga,Vickie Tsui,Matthew Volgraf,Heidi J.A. Wallweber,Jae H. Chang	2017	19
4	Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors Bioorganic & Medicinal Chemistry Letters ·Huiyong Hu,Xiaojing Wang,TİMİSİ Nilüfer,Jae H. Chang,Steven Do,Achim Hohorst,Allen Ebens,Wendy Lee,Justin Q. Ly,Joseph P. Lyssikatos,Jeremy Murray,John G. Moffat,Qi Chao,Vickie Tsui,Heidi J.A. Wallweber,Aleksandr Kolesnikov	2015	19
5	Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase Bioorganic & Medicinal Chemistry Letters ·Steven T. Staben,Nicole Blaquière,Vickie Tsui,Aleksandr Kolesnikov,Steven Do,Erin K. Bradley,Jenna Dotson,Richard Goldsmith,Timothy P. Heffron,John Lesnick,Cristina Lewis,Jeremy Murray,Jim Nonomiya,Alan G. Olivero,Jodie Pang,Lionel Rougé,Laurent Salphati,BinQing Wei,Christian Wiesmann,Ping Wu	2012	5
6	Factor VIIa inhibitors: Gaining selectivity within the trypsin family Bioorganic & Medicinal Chemistry Letters ·William D. Shrader,Aleksandr Kolesnikov,Брагин А. Н., Луцкий Г. Л., Маханьков Е. П.,Roopa Rai,PTS,Huiyong Hu,Mohammad R. Hemmati,G. Beckett,Wendy B. Young,B.A. Katz,Christine Yu,Jie Tang,Daniela De Lorenzo,Estefany Lopez Velazquez,James W. Janc,Paul A. Sprengeler	2006	12
7	Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model Bioorganic & Medicinal Chemistry Letters ·Wendy B. Young,Joyce Mordenti,М.А. Скворцов,William D. Shrader,Aleksandr Kolesnikov,Roopa Rai,Liang Liu,Huiyong Hu,Ellen M. Leahy,Michael J. Green,Paul A. Sprengeler,B.A. Katz,Christine Yu,James W. Janc,Kyle Elrod,Ulla M. Marzec,Stephen R. Hanson	2006	24
8	Potent 4-amino-5-azaindole factor VIIa inhibitors Bioorganic & Medicinal Chemistry Letters ·Huiyong Hu,Aleksandr Kolesnikov,Jennifer R. Riggs,Ünal Bulut,Peter McCaldon,Ellen M. Leahy,William D. Shrader,Paul A. Sprengeler,Michael J. Green,Estefany Lopez Velazquez,Margaret Nguyen,Vásquez Ávila,Daniela De Lorenzo,Wendy B. Young	2006	26
9	Factor VIIa inhibitors: Improved pharmacokinetic parameters Bioorganic & Medicinal Chemistry Letters ·Aleksandr Kolesnikov,Roopa Rai,Wendy B. Young,Joyce Mordenti,Liang Liu,М.А. Скворцов,William D. Shrader,Ellen M. Leahy,Huiyong Hu,Vásquez Ávila,James W. Janc,B.A. Katz,Paul A. Sprengeler	2006	9
10	Novel 5-azaindole factor VIIa inhibitors Bioorganic & Medicinal Chemistry Letters ·Jennifer R. Riggs,Huiyong Hu,Aleksandr Kolesnikov,Ellen M. Leahy,Ünal Bulut,William D. Shrader,De Francesca Af,Katja Thomale,Huoyan Jiang,Paul A. Sprengeler,Michael J. Green,Christine Yu,Theresa Gl�ckler,Estefany Lopez Velazquez,Margaret Nguyen,Daniela De Lorenzo,Wendy B. Young	2006	19
11	Discovery of novel heterocyclic factor VIIa inhibitors Bioorganic & Medicinal Chemistry Letters ·Roopa Rai,Aleksandr Kolesnikov,Paul A. Sprengeler,М.А. Скворцов,G. Beckett,B.A. Katz,Christine Yu,PTS,William D. Shrader,Peter McCaldon,Stephen Gugu,Estefany Lopez Velazquez,Wendy B. Young	2006	18
12	Factor VIIa inhibitors: A prodrug strategy to improve oral bioavailability Bioorganic & Medicinal Chemistry Letters ·Jennifer R. Riggs,Aleksandr Kolesnikov,PTS,Wendy B. Young,William D. Shrader,De Francesca Af,Peter McCaldon,Liang Liu,Lin Pan,Joyce Mordenti,Michael J. Green,Juthamas Sukbuntherng	2006	23
13	Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation Bioorganic & Medicinal Chemistry Letters ·Wendy B. Young,Paul A. Sprengeler,William D. Shrader,Yong Li,Roopa Rai,Erik Verner,Thomas E. Jenkins,S. Yu. Obudovskii,Aleksandr Kolesnikov,James W. Janc,Lynne Cregar,Kyle Elrod,Theresa Gl�ckler	2005	9
14	Novel small molecule inhibitors of c-terminal Src kinase [Csk] Cellular & Molecular Biology Letters ·B. D. Wring,Maria N. Kostjukova,Gösta Harding,Denise Chamblee,S Pappala,Maryan Nasirpour,Aleksandr Kolesnikov	2003	4
15	Optimization of a screening lead for factor VIIa/TF Bioorganic & Medicinal Chemistry Letters ·Wendy B. Young,Aleksandr Kolesnikov,Roopa Rai,Paul A. Sprengeler,Ellen M. Leahy,William D. Shrader,Joan Sangalang,Брагин А. Н., Луцкий Г. Л., Маханьков Е. П.,王焘 Wang Tao,Kyle Elrod,Lynne Cregar	2001	39
16	Development of potent and selective factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Roopa Rai,Aleksandr Kolesnikov,Yong Li,Wendy B. Young,Xun Hu,Paul A. Sprengeler,Erik Verner,William D. Shrader,Брагин А. Н., Луцкий Г. Л., Маханьков Е. П.,Joan Sangalang,Darin A. Allen,Camille Duprez,B.A. Katz,Christine Luong,Kyle Elrod,Lynne Cregar	2001	7
17	Development of Serine Protease Inhibitors Displaying a Multicentered Short (<2.3 Å) Hydrogen Bond Binding Mode: Inhibitors of Urokinase-Type Plasminogen Activator and Factor Xa Journal of Medicinal Chemistry ·Erik Verner,B.A. Katz,Jeffrey R. Spencer,Darin A. Allen,Jason Hataye,Witold N. Hruzewicz,Hon C. Hui,Aleksandr Kolesnikov,Yong Li,Christine Luong,Matthew Tranter,Kesavan Radika,Roopa Rai,Fardin Hashemzadeh,William D. Shrader,Paul A. Sprengeler,Sean Trapp,Jing Wang,Wendy B. Young,Richard L. Mackman	2001	111

About Aleksandr Kolesnikov

Aleksandr Kolesnikov is a scholar working on Hematology, Genetics and Cancer Research, having authored 17 papers that have together received 348 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Hemophilia Treatment and Research (5 papers), Protease and Inhibitor Mechanisms (4 papers), Synthesis and biological activity (3 papers), Cancer Mechanisms and Therapy (3 papers), Phytochemical compounds biological activities (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Hematology (132 citations), Genetics (100 citations) and Organic Chemistry (169 citations). Aleksandr Kolesnikov has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include William D. Shrader, Paul A. Sprengeler, Wendy B. Young, B.A. Katz, Ellen M. Leahy, Roopa Rai, Huiyong Hu, Erik Verner, Sean Trapp and Jason Hataye. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Synthesis, Xenobiotica and Cellular & Molecular Biology Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact